Did you know: LSHTM alumni receive 25% off most LSHTM-led short courses! Learn how to fit infectious disease models to real-world data with @lshtm.bsky.social's short course in London (7–10 September 2026). Build practical skills in statistical inference and model analysis. Apply at the link below!

🦠 How do you design a medicine for a virus that doesn’t even exist yet? In this video, Fanny Escudié, our Senior Discovery Project Manager, breaks down how scientists are preparing for future pandemics with broad-spectrum antivirals.

🚨@cepi.net vaccines has launched a new Call for Proposals in response to the Bundibugyo virus outbreak in the DRC and Uganda. 📅 Deadline: 12 June 2026 🔗 More: cepi.my.site.com/call-for-pro...

We welcome the new Global Action Plan on #AMR, including commitments to strengthen R&D & ensure equitable access to treatments. We look forward to the Independent Panel for Evidence for Action against AMR and stress AMR must be central in global health reform discussions. dndi.org/statements/2...

Global health is high on the agenda at #WHA79, and voices like Dr @moniquewasunna.bsky.social's remind us what progress really looks like.

'Every two weeks we now generate more lead‑optimization structural data on #dengue than we did in the previous two decades combined. The pace of the ASAP open-source project is astounding,' said @griffen-ed.bsky.social, technical director @medchemica.com. (1/3)

🌟 Applications are now open for MentorMe 2026! 🌟 MentorMe is LSHTM’s alumni mentoring programme, running from April–July 2026, bringing together alumni, students, and recent graduates for meaningful one-to-one mentoring connections.

Dr Wilfried remembers treating sleeping sickness patients with the old medicine which was so toxic it killed 1 in 20 patients. 💊 Acoziborole is a revolution since those dark days: it cures the disease with one-day treatment course & is effective for both stages of the disease. #1Dose1Cure

Acoziborole, a single‑dose oral treatment for sleeping sickness developed by @dndi.org and Sanofi, has received a positive opinion from @ema.europa.eu.Thanks to the power of science & innovation, this pill could simplify care and speed elimination. bit.ly/dndi-acozi #1Dose1Cure

❗The @sciencebusiness.net Annual Network Conference 2026 is taking place on 5 February, in Brussels Our Executive Director, Dr Michael Makanga, will be representing Global Health EDCTP3 to discuss Europe's future vision for research and innovation. 🔗Register: sciencebusiness.net/events/momen...

👩‍🔬 This #WorldNTDDay we’re also featuring Dr Shomik Maruf (MSc Medical Parasitology, 2020) — this year's Study UK Alumni Award winner for Science and Sustainability in Bangladesh, whose work spans surveillance, health systems integration, and mentorship in the fight against NTDs.

📢 Call for a postdoctoral position in virology 📍 Institute of Virology, Medical University of Innsbruck, Austria 🕘 5 years | Full-time 📅 Starting 1 April 2026 🔗 Apply: virologie.i-med.ac.at/postdoctoral... #CapacityStrengthening @geroldlab.bsky.social

🔗 Read her story 👇 www.lshtm.ac.uk/aboutus/alum... #LSHTMalumni #GlobalHealth #PublicHealth @dndi.org @moniquewasunna.bsky.social @lshtm.bsky.social

📢 Today is #WorldNTDDay! Over 1B people are affected by neglected tropical diseases. Too many still lack safe & effective treatments. 👉 Share this post to support science, innovation & global health funding. #EndTheNeglect #BeatNTDs #UniteActEliminate

“Underreporting and weak surveillance continue to cloud the true burden of NTDs,” said Sanjay Sarin, our Asia continental lead, to @nature.com India. “Cases are often missed in exactly the places where disease risk is highest.” Read more ⤵️ www.nature.com/articles/d44...

🌍 For #WorldNTDDay, we’re spotlighting @moniquewasunna.bsky.social (MSc Clinical Tropical Medicine, 1986; PhD Medicine, 1991) — whose leadership advancing equitable access to treatments and clinical research for NTDs across East Africa shows the impact of sustained collaboration.

✨We wish you a joyful holiday season & happy 2026! We deeply appreciate the colleagues, supporters, partners, & friends who have joined us in our journey putting equity at the heart of medical innovation. We look forward to continuing to innovate together in the year to come!

How does treatment for #PKDL affect the #leishmaniasis parasite and the human immune system? We need to know so that we can get the dosing right. Read more here doi.org/10.1002/cpt....

To learn about the global burden of cryptococcal disease, limitations of currently available treatments, attributes of much-needed novel treatments, and potential drug discovery and development pathways, click here www.journalofinfection.com/article/S016...

✨ As the year draws to a close, we would like to thank our partners, researchers and stakeholders for your trust, collaboration and shared commitment to advancing global health. From all of us at Global Health EDCTP3, we wish you a peaceful festive season and a bright start to 2026.

Pitch your project ideas and connect on the #InfoDay2026 networking platform Post opportunities to get noticed: 🔹 Services 🔹 Project cooperation 🔹 Expertise Register: www.b2match.com/e/info-day-a...

We’re pleased to introduce the 2025-2026 cohort of the #WithoutBordersMediaFellowship! This year, the fellows will spotlight #NTDs & gender-responsive R&D, along with the systemic barriers shaping health outcomes in #SouthAsia. tinyurl.com/3x74zku3 @gardp.bsky.social #beatNTDs

🚨 Call for #PhD candidates #PhD position in ecology and improved surveillance of Simulium vectors of human Onchocerciasis, hosted by @cirad.bsky.social 📍 Montpellier, France and Yaoundé, Cameroon 🗓️ Deadline: 24 Dec 2025 Apply: umr-intertryp.cirad.fr/en/actualite... #CapacityStrengthening

🎓Free self-paced course on Research Communication by TDR Learn to turn complex evidence into clear and persuasive messages that drive action. 📅 Available until 31 December 2026 ⏱️ 2-3 hours 🖥️ Online 👉 Enrol: tdrmooc.org/courses/cour...

Kenya’s health workforce must catch up with the rising tide of cardiometabolic diseases. Our new issue briefly outlines how stronger training, updated curriculum, and better infrastructure can equip health professionals to deliver quality CMD care. 🔗 buff.ly/NCfrt44 #APHRCResearch #IamAPHRC

Join us Nov 6 (3–4:30 PM EAT) for a webinar on bridging the gap between research & policy for #NTDs amid shifting funding. 👉 Register here: us02web.zoom.us/webinar/regi...

Once a major public health threat, kala-azar is now close to elimination in South Asia. At #WHOSEARO78, we co-hosted a high-level event with the Govt of India, the Govt of Nepal, WHO South-East Asia, and Gates Foundation India to mark 20 years of the Regional Kala-azar Elimination Initiative.

Join us at the @sciencebusiness.net conference 'Healthy competition: Can Europe regain its global edge in life sciences?' 📆 Thursday, 16 October, 11:00-11:45 📍 Brussels and online Register: sciencebusiness.net/events/healt...

🎬 Meet Henry — The Boy Who Beat The Sandfly. A powerful story of resilience, hope, and the urgent need for better treatments for children with #VisceralLeishmaniasis. 📽️ Trailer out now. Full film coming soon! #ZeroLeish #NNN2025 #GlobalHealth #KalaAzar

At #ScienceSummit #UNGA80, we chaired 'Partnering through Science: Africa–Europe Cooperation for Health #Security in a Changing #Climate.' We also met key figures from Novo Nordisk and Novartis and are excited to turn these insights into action!

Chrispin Owaga, new #NNN2025 chair for the #schistosomiasis working group, calls for a strategy shift: with global funding landscapes changing and drug donation resources dwindling, innovation in diagnostics, treatments & vaccines is more critical than ever. #beatNTDs